{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:22:41Z","timestamp":1788992561982,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00393-020-00948-3","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T17:02:38Z","timestamp":1608310958000},"page":"71-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Janus kinase inhibitors for treating active ankylosing spondylitis: a\u00a0meta-analysis of randomized controlled trials","Januskinaseinhibitoren in der Behandlung der aktiven ankylosierenden Spondylitis: Metaanalyse randomisierter kontrollierter Studien"],"prefix":"10.1007","volume":"81","author":[{"given":"Y. H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. G.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.berh.2006.02.001","volume":"20","author":"J Sieper","year":"2006","unstructured":"Sieper\u00a0J, Rudwaleit\u00a0M, Khan\u00a0MA, Braun\u00a0J (2006) Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 20:401\u2013417","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"948_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4078\/jrd.2018.25.3.197","volume":"25","author":"YH Lee","year":"2018","unstructured":"Lee\u00a0YH, Song\u00a0GG (2018) Overall and sex-specific mortality in psoriatic arthritis and ankylosing spondylitis: a meta-analysis. J\u00a0Rheum Dis 25(3):197\u2013202","journal-title":"J Rheum Dis"},{"key":"948_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4078\/jrd.2018.25.1.28","volume":"25","author":"BS Koo","year":"2018","unstructured":"Koo\u00a0BS, Lim\u00a0JW, Shin\u00a0JH, Kim\u00a0T\u2011H (2018) Characteristics of uveitis in patients with ankylosing spondylitis in Korea: a single-center survey. J\u00a0Rheum Dis 25:28\u201333","journal-title":"J Rheum Dis"},{"key":"948_CR4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde\u00a0D, Ramiro\u00a0S, Landew\u00e9\u00a0R, Baraliakos\u00a0X, Van den Bosch\u00a0F, Sepriano\u00a0A, Regel\u00a0A, Ciurea\u00a0A, Dagfinrud\u00a0H, Dougados\u00a0M (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76:978\u2013991","journal-title":"Ann Rheum Dis"},{"key":"948_CR5","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten\u00a0D, Baraliakos\u00a0X, Braun\u00a0J et al (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a\u00a0randomised, double-blind, placebo-controlled trial. Lancet 382:1705\u20131713","journal-title":"Lancet"},{"key":"948_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1126\/science.1087061","volume":"302","author":"PS Changelian","year":"2003","unstructured":"Changelian\u00a0PS, Flanagan\u00a0ME, Ball\u00a0DJ et\u00a0al (2003) Prevention of organ allograft rejection by a\u00a0specific Janus kinase 3 inhibitor. Science 302:875\u2013878","journal-title":"Science"},{"key":"948_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00001721-199404000-00003","volume":"5","author":"T Nakase","year":"1994","unstructured":"Nakase\u00a0T, Wada\u00a0H, Minamikawa\u00a0K et al (1994) Increased activated protein C\u2011protein C inhibitor complex level in patients positive for lupus anticoagulant. Blood Coagul Fibrinolysis 5:173\u2013177","journal-title":"Blood Coagul Fibrinolysis"},{"key":"948_CR8","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","volume":"394","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde\u00a0D, Song\u00a0I\u2011H, Pangan\u00a0AL, Deodhar\u00a0A, Van den Bosch\u00a0F, Maksymowych\u00a0WP, Kim\u00a0T\u2011H, Kishimoto\u00a0M, Everding\u00a0A, Sui\u00a0Y (2019) Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a\u00a0multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial. Lancet 394:2108\u20132117","journal-title":"Lancet"},{"key":"948_CR9","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","volume":"392","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde\u00a0D, Baraliakos\u00a0X, Gensler\u00a0LS, Maksymowych\u00a0WP, Tseluyko\u00a0V, Nadashkevich\u00a0O, Abi-Saab\u00a0W, Tasset\u00a0C, Meuleners\u00a0L, Besuyen\u00a0R (2018) Efficacy and safety of filgotinib, a\u00a0selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a\u00a0randomised, placebo-controlled, phase 2 trial. Lancet 392:2378\u20132387","journal-title":"Lancet"},{"key":"948_CR10","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde\u00a0D, Deodhar\u00a0A, Wei\u00a0JC, Drescher\u00a0E, Fleishaker\u00a0D, Hendrikx\u00a0T, Li\u00a0D, Menon\u00a0S, Kanik\u00a0KS (2017) Tofacitinib in patients with ankylosing spondylitis: a\u00a0phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Ann Rheum Dis 76:1340\u20131347","journal-title":"Ann Rheum Dis"},{"key":"948_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3343\/alm.2015.35.3.283","volume":"35","author":"YH Lee","year":"2015","unstructured":"Lee\u00a0YH (2015) Meta-analysis of genetic association studies. Ann Lab Med 35:283\u2013287","journal-title":"Ann Lab Med"},{"key":"948_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4078\/jrd.2019.26.4.257","volume":"26","author":"YH Lee","year":"2019","unstructured":"Lee\u00a0YH, Song\u00a0GG (2019) YKL-40 levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. J\u00a0Rheum Dis 26:257\u2013263","journal-title":"J Rheum Dis"},{"key":"948_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4078\/jrd.2020.27.1.37","volume":"27","author":"YH Lee","year":"2020","unstructured":"Lee\u00a0YH, Song\u00a0GG (2020) Associations between circulating interleukin-17 levels and systemic lupus erythematosus and between Interleukin-17 gene polymorphisms and disease susceptibility: a meta-analysis. J\u00a0Rheum Dis 27:37\u201344","journal-title":"J Rheum Dis"},{"key":"948_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad\u00a0AR, Moore\u00a0RA, Carroll\u00a0D, Jenkinson\u00a0C, Reynolds\u00a0DJ, Gavaghan\u00a0DJ, McQuay\u00a0HJ (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1\u201312","journal-title":"Control Clin Trials"},{"key":"948_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher\u00a0D, Liberati\u00a0A, Tetzlaff\u00a0J, Altman\u00a0DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264\u2013269","journal-title":"Ann Intern Med"},{"key":"948_CR16","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(05)63833-0","volume":"350","author":"G Davey Smith","year":"1997","unstructured":"Davey Smith\u00a0G, Egger\u00a0M (1997) Meta-analyses of randomised controlled trials. Lancet 350:1182","journal-title":"Lancet"},{"key":"948_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins\u00a0JP, Thompson\u00a0SG (2002) Quantifying heterogeneity in a\u00a0meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"948_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger\u00a0M, Davey Smith\u00a0G, Schneider\u00a0M, Minder\u00a0C (1997) Bias in meta-analysis detected by a\u00a0simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"948_CR19","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/S0140-6736(18)31115-2","volume":"391","author":"GR Burmester","year":"2018","unstructured":"Burmester\u00a0GR, Kremer\u00a0JM, Van den Bosch\u00a0F, Kivitz\u00a0A, Bessette\u00a0L, Li\u00a0Y, Zhou\u00a0Y, Othman\u00a0AA, Pangan\u00a0AL, Camp\u00a0HS (2018) Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a\u00a0randomised, double-blind, placebo-controlled phase 3 trial. Lancet 391:2503\u20132512","journal-title":"Lancet"},{"key":"948_CR20","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/art.41032","volume":"71","author":"R Fleischmann","year":"2019","unstructured":"Fleischmann\u00a0R, Pangan\u00a0AL, Song\u00a0IH, Mysler\u00a0E, Bessette\u00a0L, Peterfy\u00a0C, Durez\u00a0P, Ostor\u00a0AJ, Li\u00a0Y, Zhou\u00a0Y (2019) Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a\u00a0phase III, double-blind, randomized controlled trial. Arthritis Rheumatol 71:1788\u20131800","journal-title":"Arthritis Rheumatol"},{"key":"948_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","volume":"15","author":"F Seif","year":"2017","unstructured":"Seif\u00a0F, Khoshmirsafa\u00a0M, Aazami\u00a0H, Mohsenzadegan\u00a0M, Sedighi\u00a0G, Bahar\u00a0M (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal 15:23","journal-title":"Cell Commun Signal"},{"key":"948_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/annrheumdis-2018-214502","volume":"78","author":"T Sornasse","year":"2019","unstructured":"Sornasse\u00a0T, Sokolove\u00a0J, McInnes\u00a0I (2019) THU0181 treatment with upadacitinib results in the normalization of key pathobiologic pathways in patients with rheumatoid arthritis: biomarker results from the phase 3 select-next and select-beyond studies. Ann Rheum Dis 78:365\u2013366","journal-title":"Ann Rheum Dis"},{"key":"948_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3904\/kjim.2016.195","volume":"33","author":"YH Lee","year":"2018","unstructured":"Lee\u00a0YH (2018) An overview of meta-analysis for clinicians. Korean J Intern Med 33:277","journal-title":"Korean J Intern Med"},{"key":"948_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.arcmed.2012.06.011","volume":"43","author":"Y-H Lee","year":"2012","unstructured":"Lee\u00a0Y\u2011H, Bae\u00a0S\u2011C, Song\u00a0G\u2011G (2012) Omega\u20113 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a\u00a0meta-analysis. Arch Med Res 43:356\u2013362","journal-title":"Arch Med Res"},{"key":"948_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00011-012-0455-5","volume":"61","author":"YH Lee","year":"2012","unstructured":"Lee\u00a0YH, Bae\u00a0S\u2011C, Choi\u00a0SJ, Ji\u00a0JD, Song\u00a0GG (2012) Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 61:635\u2013641","journal-title":"Inflamm Res"},{"key":"948_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4078\/jrd.2019.26.2.104","volume":"26","author":"GG Song","year":"2019","unstructured":"Song\u00a0GG, Lee\u00a0YH (2019) Causal association between bone mineral density and osteoarthritis: a Mendelian randomization study. J\u00a0Rheum Dis 26:104\u2013110","journal-title":"J Rheum Dis"},{"key":"948_CR27","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","volume":"44","author":"JJ Anderson","year":"2001","unstructured":"Anderson\u00a0JJ, Baron\u00a0G, van der Heijde\u00a0D, Felson\u00a0DT, Dougados\u00a0M (2001) Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44:1876\u20131886","journal-title":"Arthritis Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00948-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-020-00948-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00948-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T19:02:59Z","timestamp":1644001379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-020-00948-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1007\/s00393-020-00948-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,18]]},"assertion":[{"value":"29 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"Y.\u00a0H.\u00a0Lee and G.\u00a0G.\u00a0Song declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}